Liwu Fu Selected Research

olmutinib

7/2018

Olmutinib (HM61713) reversed multidrug resistance by inhibiting the activity of ATP-binding cassette subfamily G member 2 in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Liwu Fu Research Topics

Disease

59	Neoplasms (Cancer) 03/2022 - 04/2004
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2021 - 09/2015
5	Lung Neoplasms (Lung Cancer) 01/2021 - 08/2015
5	Breast Neoplasms (Breast Cancer) 09/2017 - 11/2010
3	Carcinogenesis 01/2022 - 01/2019
3	Esophageal Squamous Cell Carcinoma 01/2018 - 06/2014
3	Leukemia 01/2018 - 01/2016
3	Neoplasm Metastasis (Metastasis) 01/2017 - 01/2010
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020 - 05/2011
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019 - 01/2018
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Papillary Thyroid Cancer 01/2020
1	Adenocarcinoma 01/2019
1	Type 2 Diabetes Mellitus (MODY) 11/2017
1	Acute Promyelocytic Leukemia 09/2017
1	Hepatocellular Carcinoma (Hepatoma) 08/2017
1	Retinoblastoma (Glioblastoma, Retinal) 01/2017
1	Circulating Neoplastic Cells 01/2017
1	Malignant Mesothelioma 01/2017

Drug/Important Bio-Agent (IBA)

13	Adenosine Triphosphate (ATP)IBA 05/2020 - 01/2014
12	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2019 - 01/2014
11	Pharmaceutical PreparationsIBA 01/2022 - 01/2013
10	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2010
7	Tyrosine Kinase InhibitorsIBA 05/2020 - 09/2015
6	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 12/2019 - 11/2010
5	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2013
4	Immune Checkpoint InhibitorsIBA 10/2021 - 01/2020
4	ErbB Receptors (EGF Receptor)IBA 01/2021 - 09/2015
3	Oncogene Proteins (Oncogene Protein)IBA 01/2022 - 04/2016
3	multidrug resistance-associated protein 1IBA 09/2017 - 11/2010
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2013 - 11/2010
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2022 - 05/2019
2	B7-H1 AntigenIBA 01/2021 - 01/2020
2	osimertinibIBA 01/2021 - 01/2016
2	Conditioned Culture MediaIBA 01/2021 - 01/2010
2	Antineoplastic Agents (Antineoplastics)IBA 06/2020 - 01/2014
2	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2019
2	Drug CombinationsIBA 01/2020 - 01/2018
2	CalciumIBA 01/2019 - 01/2018
2	ceritinibIBA 01/2018 - 12/2015
2	Anaplastic Lymphoma KinaseIBA 01/2017 - 12/2015
2	Adenosine Triphosphatases (ATPase)IBA 01/2017 - 08/2015
2	Antiviral Agents (Antivirals)IBA 02/2016 - 10/2014
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2015 - 10/2012
2	Topotecan (Hycamtin)FDA LinkGeneric 08/2015 - 01/2015
1	lazertinibIBA 03/2022
1	F-Box ProteinsIBA 01/2022
1	mirdametinibIBA 10/2021
1	Small Interfering RNA (siRNA)IBA 10/2021
1	ClathrinIBA 01/2021
1	Aldehyde DehydrogenaseIBA 01/2021
1	Neutralizing AntibodiesIBA 01/2021
1	rho-Associated KinasesIBA 06/2020
1	rociletinibIBA 05/2020
1	vorolanibIBA 03/2020
1	bcr-abl Fusion ProteinsIBA 01/2020
1	UbiquitinIBA 01/2020
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2020
1	AntibodiesIBA 01/2020
1	Tumor Biomarkers (Tumor Markers)IBA 01/2020
1	Ligases (Synthetase)IBA 01/2020
1	Cadherins (E-Cadherin)IBA 01/2020
1	Circular RNAIBA 01/2020
1	Granzymes (Granzyme)IBA 01/2020
1	Glucose Transporter Type 2IBA 01/2020
1	VimentinIBA 01/2020
1	CTLA-4 AntigenIBA 01/2020
1	Imatinib Mesylate (Gleevec)FDA Link 01/2020
1	Member 2 Subfamily G ATP Binding Cassette TransporterIBA 05/2019
1	secalonic acidIBA 05/2019
1	mitochondrial calcium uniporterIBA 01/2019
1	Mediator ComplexIBA 01/2019
1	conglobatinIBA 01/2019
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2018
1	Carcinoembryonic AntigenIBA 12/2018
1	Proteolysis Targeting ChimeraIBA 10/2018
1	olmutinibIBA 07/2018
1	dacomitinibIBA 02/2018
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2018
1	NF-kappa B (NF-kB)IBA 01/2018
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018
1	RP4010IBA 01/2018
1	Peptides (Polypeptides)IBA 11/2017
1	Glucose (Dextrose)FDA LinkGeneric 11/2017
1	Arsenic Trioxide (Trisenox)FDA Link 09/2017
1	abemaciclibIBA 01/2017
1	AfatinibIBA 01/2017
1	Biological ProductsIBA 01/2017
1	AsbestosIBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2017
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2017
1	alectinibIBA 01/2017

Therapy/Procedure

21	Drug Therapy (Chemotherapy) 05/2020 - 04/2004
17	Therapeutics 01/2022 - 01/2010
3	Radiotherapy 01/2020 - 08/2015
2	Immunotherapy 10/2021 - 01/2021
2	Combination Drug Therapy (Combination Chemotherapy) 12/2015 - 12/2015
1	Precision Medicine 01/2021